Dinglin Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

Drug delivery

Journal of nanobiotechnology

Science advances

ACS biomaterials science & engineering

Army Medical University

Sichuan University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Army Medical University Jun 1o 2017

China

Associate Proffesor :: Department of Chemistry, College of Basic Medicine

Education History

Sichuan University

China

PHD :: Chemistry

Publications

Shan Li, Tianyu Wu, Jingfeng Wu, Jiangling Zhou, Hong Yang, Lei Chen, Wensheng Chen, Dinglin Zhang
Cyclosporine A-Encapsulated pH/ROS Dual-Responsive Nanoformulations for the Targeted Treatment of Colitis in Mice. ACS biomaterials science & engineering (2023)
Yu Wang, Qianmei Wang, Xiaowen Wang, Pu Yao, Qing Dai, Xiaowei Qi, Ming Yang, Xiao Zhang, Rong Huang, Jing Yang, Qian Wang, Peiyuan Xia, Dinglin Zhang, Fengjun Sun
Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer. Journal of nanobiotechnology 21 (1) (2023)
Qian Ju, Rong Huang, Ruimin Hu, Junjie Fan, Dinglin Zhang, Jun Ding, Rong Li
Phytic acid-modified manganese dioxide nanoparticles oligomer for magnetic resonance imaging and targeting therapy of osteosarcoma. Drug delivery 30 (1) (2023)
Yang Yang, Ruimin Hu, Jun Zheng, Qianmei Wang, Senlin Xu, Zhansong Zhou, Dinglin Zhang, Wenhao Shen
Glucocorticoid nanoformulations relieve chronic pelvic pain syndrome and may alleviate depression in mice. Journal of nanobiotechnology 21 (1) (2023)
Qian Ju, Rong Huang, Ruimin Hu, Junjie Fan, Dinglin Zhang, Jun Ding, Rong Li
Phytic acid-modified manganese dioxide nanoparticles oligomer for magnetic resonance imaging and targeting therapy of osteosarcoma. Drug delivery 30 (1) (2023)
Qian Ju, Rong Huang, Ruimin Hu, Junjie Fan, Dinglin Zhang, Jun Ding, Rong Li
Phytic acid-modified manganese dioxide nanoparticles oligomer for magnetic resonance imaging and targeting therapy of osteosarcoma. Drug delivery 30 (1) (2023)
Fengjun Sun, Yu Wang, Qianmei Wang, Xiaowen Wang, Pu Yao, Wei Feng, Qian Yuan, Xiaowei Qi, Sheng Chen, Wendan Pu, Rong Huang, Qing Dai, Jun Lv, Qian Wang, Wenhao Shen, Peiyuan Xia, Dinglin Zhang
Self-Illuminating Triggered Release of Therapeutics from Photocleavable Nanoprodrug for the Targeted Treatment of Breast Cancer. ACS applied materials & interfaces 14 (7) (2022)
Rong Huang, Jun Hu, Wei Qian, Liang Chen, Dinglin Zhang
Recent advances in nanotherapeutics for the treatment of burn wounds. Burns & trauma 9 (2021)
Yu Wang, Qianmei Wang, Wei Feng, Qian Yuan, Xiaowei Qi, Sheng Chen, Pu Yao, Qing Dai, Peiyuan Xia, Dinglin Zhang, Fengjun Sun
Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment. Drug delivery 28 (1) (2021)
Yu Wang, Qian Yuan, Wei Feng, Wendan Pu, Jun Ding, Hongjun Zhang, Xiaoyu Li, Bo Yang, Qing Dai, Lin Cheng, Jinyu Wang, Fengjun Sun, Dinglin Zhang
Targeted delivery of antibiotics to the infected pulmonary tissues using ROS-responsive nanoparticles. Journal of nanobiotechnology 17 (1) (2019)
Xiaoqiu Xu, Hui-Jie An, Dinglin Zhang, Hui Tao, Xiaohui Li, Jun Huang, Jianxiang Zhang
A self-illuminating nanoparticle for inflammation imaging and cancer therapy. Science advances 5 (1) (2019)

Dinglin Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dinglin Zhang